跳至主要内容
临床试验/CTRI/2020/11/029064
CTRI/2020/11/029064尚未招募未知

Efficacy and adverse effects of intravitreal triamcilone and bevacizumab on macular thickness and visual acuity in patients with diabetic macular edema.

Father muller medical college0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Definite retinal thickening resulting from diabetic macular edema on clinical examination involving centre of macula.
  • Diabetic macular edema confirmed via retinal thickness measured on optical coherence tomography.

排除标准

  • Vitreous haemorrhage.
  • History of any intraocular surgery/ photocoagulation within previous 3 months.
  • History of periocular or intraocular drug injection.
  • Any corneal opacity or cataract which affects pre operative OCT evaluation.
  • Previous history of glaucoma treatment.
  • Any other ocular comorbidities that has influence on macular thickness.
  • Age less than 20 years

研究者

发起方
Father muller medical college

相似试验